Literature DB >> 18211283

Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells.

S Kuçi1, Z Kuçi, S Schmid, G Seitz, I Müller, A Dufke, T Leimig, G Murti, R Jurecic, M Schumm, P Lang, G Bruchelt, P Bader, T Klingebiel, D Niethammer, R Handgretinger.   

Abstract

OBJECTIVES: To generate non-haematopoietic tissues from mobilized haematopoietic CD133(+) stem cells.
MATERIALS AND METHODS: Mobilized peripheral blood CD133(+) cells from adult healthy donors were used. In vitro ability of highly enriched CD133(+) cells from mobilized peripheral blood to generate multipotent cells, and their potential to give rise to cells with characteristics of neuroectoderm, endoderm and mesoderm layers was investigated.
RESULTS: We found that a recently identified population of CD45(+) adherent cells generated in vitro after culture of highly purified CD133(+) cells for 3-5 weeks with Flt3/Flk2 ligand and interleukin-6 can, in presence of the appropriate microenvironmental cues, differentiate into neural progenitor-like cells (NPLCs), hepatocyte-like cells and skeletal muscle-like cells. We have termed them to be adult multipotent haematopoietic cells (AMHCs). AMHC-derived NPLCs expressed morphological, phenotypic and molecular markers associated with primary neural progenitor cells. They can differentiate into astrocyte-like cells, neuronal-like cells and oligodendrocyte-like cells. Moreover, AMHC-derived NPLCs produced 3,4-dihydrophenylalanine and dopamine and expressed voltage-activated ion channels, suggesting their functional maturation. In addition, AMHC-derived hepatocyte-like cells and skeletal muscle-like cells, showed typical morphological features and expressed primary tissue-associated proteins.
CONCLUSION: Our data demonstrate that AMHCs may therefore serve as a novel source of adult multipotent cells for autologous replacement cell therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211283      PMCID: PMC6495269          DOI: 10.1111/j.1365-2184.2007.00502.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  32 in total

Review 1.  Can stem cells cross lineage boundaries?

Authors:  D J Anderson; F H Gage; I L Weissman
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

2.  Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells.

Authors:  M Reyes; T Lund; T Lenvik; D Aguiar; L Koodie; C M Verfaillie
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

3.  Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion.

Authors:  Naohiro Terada; Takashi Hamazaki; Masahiro Oka; Masanori Hoki; Diana M Mastalerz; Yuka Nakano; Edwin M Meyer; Laurence Morel; Bryon E Petersen; Edward W Scott
Journal:  Nature       Date:  2002-03-13       Impact factor: 49.962

4.  Adult cardiac stem cells are multipotent and support myocardial regeneration.

Authors:  Antonio P Beltrami; Laura Barlucchi; Daniele Torella; Mathue Baker; Federica Limana; Stefano Chimenti; Hideko Kasahara; Marcello Rota; Ezio Musso; Konrad Urbanek; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Piero Anversa
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

5.  Hematopoietic stem cells convert into liver cells within days without fusion.

Authors:  Yoon-Young Jang; Michael I Collector; Stephen B Baylin; Anna Mae Diehl; Saul J Sharkis
Journal:  Nat Cell Biol       Date:  2004-05-09       Impact factor: 28.824

6.  Failure of transdifferentiation of adult hematopoietic stem cells into neurons.

Authors:  Laurent Roybon; Zhi Ma; Fredrik Asztely; Anna Fosum; Sten Eirik W Jacobsen; Patrik Brundin; Jia-Yi Li
Journal:  Stem Cells       Date:  2006-03-23       Impact factor: 6.277

7.  Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo.

Authors:  Sui Zhang; Dachun Wang; Zeev Estrov; Sean Raj; James T Willerson; Edward T H Yeh
Journal:  Circulation       Date:  2004-12-13       Impact factor: 29.690

8.  Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages.

Authors:  Raewyn M Seaberg; Simon R Smukler; Timothy J Kieffer; Grigori Enikolopov; Zeenat Asghar; Michael B Wheeler; Gregory Korbutt; Derek van der Kooy
Journal:  Nat Biotechnol       Date:  2004-08-22       Impact factor: 54.908

9.  Failure of hepatocyte marker-expressing hematopoietic progenitor cells to efficiently convert into hepatocytes in vitro.

Authors:  Gewei Lian; Chengyan Wang; Chunbo Teng; Cong Zhang; Liying Du; Qian Zhong; Chenglin Miao; Mingxiao Ding; Hongkui Deng
Journal:  Exp Hematol       Date:  2006-03       Impact factor: 3.084

10.  Biology and plasticity of CD133+ hematopoietic stem cells.

Authors:  Rupert Handgretinger; Paul R Gordon; Thasia Leimig; Xiaohua Chen; Hans-Jorg Buhring; Dietrich Niethammer; Selim Kuci
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

View more
  9 in total

1.  Comparing stemness gene expression between stem cell subpopulations from peripheral blood and adipose tissue.

Authors:  Maria Teresa González-Garza; Delia E Cruz-Vega; Alejandro Cárdenas-Lopez; Rosa Maria de la Rosa; Jorge E Moreno-Cuevas
Journal:  Am J Stem Cells       Date:  2018-06-01

Review 2.  From cellular to chemical approach for acute neural and alternative options for age-induced functional diseases.

Authors:  Antonin Bukovsky
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

Review 3.  Immune physiology in tissue regeneration and aging, tumor growth, and regenerative medicine.

Authors:  Antonin Bukovsky; Michael R Caudle; Ray J Carson; Francisco Gaytán; Mahmoud Huleihel; Andrea Kruse; Heide Schatten; Carlos M Telleria
Journal:  Aging (Albany NY)       Date:  2009-02-13       Impact factor: 5.682

4.  Differentiation of CD133+ stem cells from amyotrophic lateral sclerosis patients into preneuron cells.

Authors:  Maria Teresa González-Garza; Héctor R Martínez; Enrique Caro-Osorio; Delia E Cruz-Vega; Martin Hernández-Torre; Jorge E Moreno-Cuevas
Journal:  Stem Cells Transl Med       Date:  2013-01-22       Impact factor: 6.940

5.  MRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat glioma.

Authors:  Branislava Janic; Kourosh Jafari-Khouzani; Abbas Babajani-Feremi; A S M Iskander; Nadimpalli Ravi S Varma; Meser M Ali; Robert A Knight; Ali S Arbab
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

6.  Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury.

Authors:  Joan E Nichols; Jean A Niles; Douglas DeWitt; Donald Prough; Margaret Parsley; Stephanie Vega; Andrea Cantu; Eric Lee; Joaquin Cortiella
Journal:  Stem Cell Res Ther       Date:  2013-01-06       Impact factor: 6.832

Review 7.  Glial cell lines: an overview.

Authors:  George H De Vries; Anne I Boullerne
Journal:  Neurochem Res       Date:  2010-12-03       Impact factor: 3.996

8.  Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion.

Authors:  Branislava Janic; Austin M Guo; A S M Iskander; Nadimpalli Ravi S Varma; Alfonso G Scicli; Ali S Arbab
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

9.  Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes.

Authors:  Ranjithkumar Rajendran; Gregor Böttiger; Niklas Dentzien; Vinothkumar Rajendran; Bischand Sharifi; Süleyman Ergün; Christine Stadelmann; Srikanth Karnati; Martin Berghoff
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.